1. Home
  2. AMLX vs IBTA Comparison

AMLX vs IBTA Comparison

Compare AMLX & IBTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AMLX
  • IBTA
  • Stock Information
  • Founded
  • AMLX 2014
  • IBTA 2011
  • Country
  • AMLX United States
  • IBTA United States
  • Employees
  • AMLX N/A
  • IBTA N/A
  • Industry
  • AMLX Biotechnology: Pharmaceutical Preparations
  • IBTA
  • Sector
  • AMLX Health Care
  • IBTA
  • Exchange
  • AMLX Nasdaq
  • IBTA Nasdaq
  • Market Cap
  • AMLX 749.9M
  • IBTA 892.4M
  • IPO Year
  • AMLX 2022
  • IBTA 2024
  • Fundamental
  • Price
  • AMLX $12.77
  • IBTA $26.78
  • Analyst Decision
  • AMLX Strong Buy
  • IBTA Hold
  • Analyst Count
  • AMLX 7
  • IBTA 10
  • Target Price
  • AMLX $14.86
  • IBTA $44.33
  • AVG Volume (30 Days)
  • AMLX 2.0M
  • IBTA 486.4K
  • Earning Date
  • AMLX 11-06-2025
  • IBTA 11-12-2025
  • Dividend Yield
  • AMLX N/A
  • IBTA N/A
  • EPS Growth
  • AMLX N/A
  • IBTA 2512.20
  • EPS
  • AMLX N/A
  • IBTA 2.84
  • Revenue
  • AMLX N/A
  • IBTA $367,604,000.00
  • Revenue This Year
  • AMLX N/A
  • IBTA N/A
  • Revenue Next Year
  • AMLX N/A
  • IBTA $7.41
  • P/E Ratio
  • AMLX N/A
  • IBTA $9.48
  • Revenue Growth
  • AMLX N/A
  • IBTA 3.49
  • 52 Week Low
  • AMLX $2.60
  • IBTA $22.50
  • 52 Week High
  • AMLX $13.07
  • IBTA $79.80
  • Technical
  • Relative Strength Index (RSI)
  • AMLX 82.10
  • IBTA 43.38
  • Support Level
  • AMLX $11.42
  • IBTA $26.00
  • Resistance Level
  • AMLX $12.25
  • IBTA $27.51
  • Average True Range (ATR)
  • AMLX 0.59
  • IBTA 1.15
  • MACD
  • AMLX 0.21
  • IBTA 0.40
  • Stochastic Oscillator
  • AMLX 91.70
  • IBTA 45.68

About AMLX Amylyx Pharmaceuticals Inc.

Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorder and endocrine conditions.

About IBTA Ibotta Inc. Class A Common Stock

Ibotta Inc is a performance marketing platform. It allows CPG brands to deliver digital promotions to consumers through a single, convenient network called the Ibotta Performance Network (IPN).

Share on Social Networks: